On The Improvement Of China's Vaccine Safety Supervision System

Vaccines are strategic and commonweal products in China,the contents is very rich.In addition to preventing immune effects,On the one hand,Vaccine safety concerning people's right to live & health;On the other hand,it affects public health security and national security.With the release of the investigation results of "Changchun Changsheng" vaccine incident,the adoption of “Vaccine Administration Law of the People's Republic of China” in the Eleventh Session of the Standing Committee of the 13 th National People's Congress,The issue of vaccine safety has received widespread attention from the whole society.China is a big country of vaccine production and use,so the emergence of problematic vaccines seriously affects lives and health of billions of citizens across the country,which is not only a matter of product quality.How to improve the administrative supervision system and effectively implement the vaccine supervision laws and regulations is an important task to further improve the level of vaccine supervision in China.The "Shandong Vaccine Case" and "Changchun Longevity" vaccine incidents brought the public awake,but also brought reflection: how to improve China's vaccine supervision level from the aspect of administrative supervision,so that the vaccine quality and citizens' right to life and health are effectively guaranteed.As a public power,the vaccine supervision power should have a legitimacy foundation.It should not only have the legitimacy of power setting in power generation,content and attributes,but also be restricted by substantive law and procedural law during the exercise of power.The legitimacy of power exercise.Under the premise that the regulatory power has a legitimate basis,it analyzes the construction process of China's vaccine regulatory system,including the evolution of legal norms,regulatory agencies,and specific regulatory systems.Comparing China and the United States and Japan in vaccine regulation laws and regulations,the establishment of regulatory agencies and the professionalism of personnel performing supervision duties,it can be seen that China's laws and regulations are relatively complete and professional,but the degree of specialization and diversification of regulators should be further improved Regulatory body.Through the foregoing analysis,we found that China has a single regulatory body,unclear assignment of responsibilities,excessive reliance on administrative supervision,unclear channels for information disclosure,and incomplete relief procedures.It is necessary to improve the supervision system from the following aspects: setting up an independent supervision agency,clarifying the responsibilities of the supervision subject,ensuring the clarity of the information disclosure channel and content,clarifying the compensation standard for vaccination abnormal reactions,adding reporting subjects and identification subjects to ensure adverse reactions The fairness of the reporting system.Facing the current situation,on the one hand,it is necessary to further improvethe vaccine regulatory system;on the other hand,it is necessary to call on vaccine regulatory agencies,vaccine manufacturers and other entities to abide by laws and industry norms to ensure vaccine safety in the development and production of new coronavirus vaccines Safeguard the public interest.